1. Home
  2. EHTH vs PMN Comparison

EHTH vs PMN Comparison

Compare EHTH & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.61

Market Cap

104.0M

Sector

Finance

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$10.72

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
PMN
Founded
1997
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Specialty Insurers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
115.5M
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
EHTH
PMN
Price
$1.61
$10.72
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$3.33
$42.67
AVG Volume (30 Days)
332.4K
17.0K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$0.29
52 Week High
$5.89
$27.40

Technical Indicators

Market Signals
Indicator
EHTH
PMN
Relative Strength Index (RSI) 47.72 50.94
Support Level $1.64 $9.20
Resistance Level $1.72 $11.37
Average True Range (ATR) 0.13 0.73
MACD 0.01 0.12
Stochastic Oscillator 51.54 70.73

Price Performance

Historical Comparison
EHTH
PMN

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: